Nasal Decongestants
Research News and Information

Sunday, November 22, 2009

Allergic rhinitis: background, symptoms, diagnosis and treatment options.

30 Jul 2009 This one-part unit outlines the symptoms, diagnosis and various treatment options for allergic rhinitis. It also highlights nurses' roles in the management of this common ... Read more...

Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care.

30 Jul 2009 BACKGROUND AND OBJECTIVES: Symptomatic medications are often not considered in clinical studies assessing interventions to reduce prescribing of antibiotics for acute respiratory tract infections (ARTI). Our study objectives were to examine ... Read more...

Nasal congestion index: A measure for nasal obstruction.

30 Jul 2009 OBJECTIVES: The relationship between congestion of the nasal mucosa and subjective nasal obstruction remains poorly defined. Applying the novel Nasal Congestion Index (NCI), we compared subjective nasal obstruction with objective measures for ... Read more...

Latest indexed articles for 'Nasal Decongestants'

These are the very latest articles for this heading:

• Over-the-counter medications: Zicam nasal products may cause loss of sense of smell... 30 Aug 2009
• Allergic rhinitis: background, symptoms, diagnosis and treatment options. 30 Jul 2009
• Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care. 30 Jul 2009
• Nasal congestion index: A measure for nasal obstruction. 30 Jul 2009
• More discussion of over the counter cough and cold preparations. 30 Jul 2009
• Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. 29 Jun 2009
• Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils. 29 Jun 2009
• Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms. 7 Jun 2009
• [Pollen allergy and pregnancy. A literature review of anti-allergic agents shows no increased risk of fetal injuries] 30 May 2009
• For young children, many OTC products are out in the cold. 30 May 2009
• Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion. 30 May 2009
• Management of chronic rhinosinusitis in CF. 30 May 2009
• Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. 30 May 2009
• Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections. 29 Apr 2009
• Influence of the ageing phenomenon on the low-frequency electrical impedance behavior of naphazoline hydrochloride solutions and paracetamol syrup. 29 Apr 2009
• WITHDRAWN: Nasal decongestants for the common cold. 13 Apr 2009
• Managing acute sinusitis. 27 Feb 2009
• Objective assessment of internal nasal dimensions and speech resonance in individuals with repaired unilateral cleft lip and palate after rhinoseptoplasty. 27 Feb 2009
• Exanthematic reaction to pseudoephedrine. 27 Feb 2009
• [Sinusitis] 2 Feb 2009

See a longer list of these articles.

Technical information about 'Nasal Decongestants'

Definition: Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Registry Number: 0

Descriptor UI: D014663

Alternative terms: Nasal Decongestants; Decongestants, Nasal; Decongestants; Vasoconstrictor Agents, Nasal; Agents, Nasal Vasoconstrictor; Nasal Vasoconstrictor Agents; Vasoconstrictors, Nasal; Nasal Vasoconstrictors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.793.610; D27.505.954.796.560;

History Note: 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95

Technical Notes: Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL